Literature DB >> 1445850

Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity.

T Miida1, M Kawano, C J Fielding, P E Fielding.   

Abstract

A minor fraction of plasma high-density lipoprotein (pre beta-1 HDL) has been shown to promote cholesterol efflux from peripheral cell membranes [Castro, G. R., & Fielding, C. J. (1988) Biochemistry 27, 25-29]. When isolated native plasma is incubated at 37 degrees C, this fraction is specifically decreased. On the other hand, the level of plasma pre beta-1 HDL is fully protected in the presence of even very low levels of fibroblasts, vascular smooth muscle cells, or macrophages. Blood cells were completely inactive in maintaining plasma pre beta-1 HDL levels in the absence of peripheral cells, even at the relatively high levels present in whole blood. The loss of pre beta-1 observed in isolated plasma was dependent upon lecithin-cholesterol acyltransferase (LCAT) activity. These data suggest that reverse cholesterol transport catalyzed by pre beta-1 HDL, and subsequent LCAT-mediated cholesterol esterification, is directly dependent upon the interaction between this HDL species and competent peripheral cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445850     DOI: 10.1021/bi00160a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Direct measurement of HDL cholesterol: method eliminating apolipoprotein E-rich particles.

Authors:  M Okada; H Matsui; Y Ito; A Fujiwara
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol.

Authors:  W V Rodrigueza; K J Williams; G H Rothblat; M C Phillips
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-02       Impact factor: 8.311

4.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

5.  Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Authors:  Bela F Asztalos; Dorothea Collins; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

6.  Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.

Authors:  O L Francone; E L Gong; D S Ng; C J Fielding; E M Rubin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Authors:  Osamu Miyazaki; Jun Ogihara; Isamu Fukamachi; Takafumi Kasumi
Journal:  J Lipid Res       Date:  2013-12-04       Impact factor: 5.922

8.  High-density lipoproteins and the immune system.

Authors:  Hidesuke Kaji
Journal:  J Lipids       Date:  2013-01-30

9.  Relationship between apolipoprotein concentrations and HDL subclasses distribution.

Authors:  Li Tian; Mingde Fu; Lianqun Jia; Yanhua Xu; Shiyin Long; Haoming Tian; Ying Tian
Journal:  Lipids       Date:  2007-03-08       Impact factor: 1.646

10.  Tachometer for reverse cholesterol transport?

Authors:  Arnold Eckardstein
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.